Found: 19
Select item for more details and to access through your institution.
Scriptaid enhances skeletal muscle insulin action and cardiac function in obese mice.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 936, doi. 10.1111/dom.12896
- By:
- Publication type:
- Article
Placebo-controlled, randomized trial of the addition of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes ( AWARD-9).
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 1024, doi. 10.1111/dom.12937
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 913, doi. 10.1111/dom.12772
- Publication type:
- Article
Insulin degludec: Lower day-to-day and within-day variability in pharmacodynamic response compared with insulin glargine 300 U/ mL in type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 1032, doi. 10.1111/dom.12938
- By:
- Publication type:
- Article
Delays in treatment intensification with oral antidiabetic drugs and risk of microvascular and macrovascular events in patients with poor glycaemic control: An individual patient simulation study.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 1006, doi. 10.1111/dom.12913
- By:
- Publication type:
- Article
Comparison of body mass index at diagnosis of diabetes in a multi-ethnic population: A case-control study with matched non-diabetic controls.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 1014, doi. 10.1111/dom.12915
- By:
- Publication type:
- Article
Short-acting glucagon-like peptide-1 receptor agonists as add-on to insulin therapy in type 1 diabetes: A review.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 915, doi. 10.1111/dom.12911
- By:
- Publication type:
- Article
AMP-activated protein kinase ( AMPK) activator A-769662 increases intracellular calcium and ATP release from astrocytes in an AMPK-independent manner.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 997, doi. 10.1111/dom.12912
- By:
- Publication type:
- Article
Effect of exercise combined with glucagon-like peptide-1 receptor agonist treatment on cardiac function: A randomized double-blind placebo-controlled clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 1040, doi. 10.1111/dom.12900
- By:
- Publication type:
- Article
Comparison of the effects of diets high in animal or plant protein on metabolic and cardiovascular markers in type 2 diabetes: A randomized clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 944, doi. 10.1111/dom.12901
- By:
- Publication type:
- Article
Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon-like peptide-1 receptor agonists: Higher adherence and persistence with dulaglutide compared with once-weekly exenatide and liraglutide.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 953, doi. 10.1111/dom.12902
- By:
- Publication type:
- Article
Lipid-lowering efficacy and safety of alirocumab in patients with or without diabetes: A sub-analysis of ODYSSEY COMBO II.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 989, doi. 10.1111/dom.12909
- By:
- Publication type:
- Article
Baseline adiponectin concentration and clinical outcomes among patients with diabetes and recent acute coronary syndrome in the EXAMINE trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 962, doi. 10.1111/dom.12905
- By:
- Publication type:
- Article
No increased risk of cardiovascular events in older adults initiating dipeptidyl peptidase-4 inhibitors vs therapeutic alternatives.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 970, doi. 10.1111/dom.12906
- By:
- Publication type:
- Article
Evaluation of subcutaneous glucose monitoring systems under routine environmental conditions in patients with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 1051, doi. 10.1111/dom.12907
- By:
- Publication type:
- Article
Hypoglycaemia manifestations and recurrent events: Lessons from the SAVOR-TIMI 53 outcome study.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 1045, doi. 10.1111/dom.12903
- By:
- Publication type:
- Article
Efficacy and safety of autoinjected exenatide once-weekly suspension versus sitagliptin or placebo with metformin in patients with type 2 diabetes: The DURATION-NEO-2 randomized clinical study.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 979, doi. 10.1111/dom.12908
- By:
- Publication type:
- Article
Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 926, doi. 10.1111/dom.12924
- By:
- Publication type:
- Article
News and Views.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 1056, doi. 10.1111/dom.12992
- By:
- Publication type:
- Article